Cited by 320Rheumatoid Arthritis Research and TherapiesBiomarkers in Disease MechanismsAdipokines, Inflammation, and Metabolic Diseases

C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

Open access
Pope, Janet E., Choy, Ernest H.·2021·Seminars in Arthritis and Rheumatism

Abstract

C-reactive protein (CRP) is routinely assessed as a marker of systemic inflammation in rheumatoid arthritis (RA). However, it is also an immune regulator that plays an important role in inflammatory pathways associated with RA and promotes atherogenic effects. Comorbidities linked to systemic inflammation are common in RA, and CRP has been associated with the risk for cardiovascular disease, diabetes, metabolic syndrome, pulmonary diseases, and depression. The relationship between systemic inflammation, CRP, and comorbidities in RA is complex, and it is challenging to determine how changing CRP levels may affect the risk or progression of these comorbidities. We review the biological role of CRP in RA and its implications for disease activity and treatment response. We also discuss the impact of treatment on CRP levels and whether reducing systemic inflammation and inhibiting CRP-mediated inflammatory pathways may have an impact on conditions commonly comorbid with RA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semarthrit.2020.11.005

Cites

221 of 221 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals affected with autoimmune disorders are more likely to display comorbid depressive symptomatology.

    “Accordingly, it has been well documented that individual affected with autoimmune disorders (e.g., rheumatoid arthritis, psoriasis, diabetes mellitus, chronic inflammatory bowel disease, and autoimmune thyroiditis) are more likely to display comorbid depressive symptomatology [17,18,19,20,21,22,23].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pope, J. E., & Choy, E. H.
Affiliations
  • Western University (CA)
  • Cardiff University (GB)
Corresponding author
Choy, Ernest H.
Venue
Seminars in Arthritis and Rheumatism
Publisher
Elsevier BV
Published
2021-02
Volume
51
Issue
1
Pages
219-229
ISSN
0049-0172 (ISSN-L)
OpenAlex
W3112789381
Cited by
320
References
221
Citations by year
2026: 47 · 2025: 80 · 2024: 85 · 2023: 49 · 2022: 41 · 2021: 17
FWCI
4.15
Type
journal article
Language
en
Open access
Locations
  • Seminars in Arthritis and Rheumatism (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
Funders
Sanofi Genzyme
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
C-reactive protein, rheumatoid arthritis, systemic inflammation, comorbidities, cardiovascular disease, diabetes mellitus, metabolic syndrome, lung disease, depression, disease activity, treatment response, atherogenic effects, inflammatory signaling
MeSH terms
Arthritis, Rheumatoid, C-Reactive Protein, Cardiovascular Diseases, Humans, Inflammation, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review